RAPT
RAPT
NASDAQ · Biotechnology

Rapt Therapeutics Inc

$58.02
+0.04 (+0.07%)
As of Aug 1, 1:38 AM ET ·
Analyst Consensus
Hold
17
Analysts
High
Coverage
Buy 6 35%
Hold 11 65%
Sell 0 0%
Price Target
Analyst Price Target -54.6% upside
Low Target $18.77
Average Target $26.34
High Target $31.12
Current Price $58.02
Current
$58.02
Target
$26.34
$18.77 $26.34 avg $31.12
Scenario Analysis
Bear Case
$18.77
-67.6%
Low target
Base Case
$26.34
-54.6%
Avg target
Bull Case
$31.12
+-46.4%
High target
Risk/Reward
0.7x
Unfavorable
Price in Context
52-Week High
$58.02
0.0% from high
52-Week Low
$8.75
+563.1% from low
Target vs 52W High
$26.34
-54.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 +4.7%
AMGN
Amgen Inc
Hold 43 49% $190.87 -53.6%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +172.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 37 81% $438.34 -11.6%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -90.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -55.6%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -44.4%
BIIB
Biogen Inc
Buy 43 67% $91.45 -56.0%